Need for discriminating between diagnostic and screening efficacy to estimate a biomarker based on case control and cohort studies
Abstract This study proposes the comprehensive index of biomarker (CIB), based on the consistency of a biomarker in case control (Youden index, J) and cohort studies (Crc), to evaluate biomarker efficacy. CIB was calculated as the mean of J and Crc. Analysis of the effect of sensitivity and specific...
Guardado en:
Autor principal: | Liu Hui |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3a69fbe12ad4413f9715a65a1df8e2bd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Estimating the efficacy of symptom-based screening for COVID-19
por: Alison Callahan, et al.
Publicado: (2020) -
Diagnostic Model for Discrimination Between Tuberculous Meningitis and Bacterial Meningitis
por: Ying Luo, et al.
Publicado: (2021) -
Microarray-based selection of a serum biomarker panel that can discriminate between latent and active pulmonary TB
por: Zhihui Li, et al.
Publicado: (2021) -
AcalPred: a sequence-based tool for discriminating between acidic and alkaline enzymes.
por: Hao Lin, et al.
Publicado: (2013) -
Biomarkers for prediction and diagnostics of preeclampsia
por: O. V. Radkov, et al.
Publicado: (2018)